Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Kimberly A Morishita1, Linda Wagner-Weiner2, Eric Y Yen3

  • 1British Columbia's Children's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Standardized treatment plans for severe pediatric antineutrophil cytoplasmic antibody-associated vasculitis (AAV) were established through consensus. These plans aim to facilitate future comparative effectiveness and safety studies in pediatric AAV management.

Area of Science:

  • Pediatric Rheumatology
  • Vasculitis Research
  • Clinical Consensus

Background:

  • Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) lacks standardized treatment protocols in pediatric populations.
  • The rarity of pediatric AAV precludes large-scale randomized controlled trials.
  • Severe pediatric AAV requires urgent and effective management strategies.

Purpose of the Study:

  • To establish consensus treatment plans (CTPs) for severe pediatric AAV.
  • To enable future studies on the comparative effectiveness and safety of AAV treatments.
  • To provide standardized approaches for managing new-onset granulomatosis with polyangiitis, microscopic polyangiitis, and renal-limited AAV in children.

Main Methods:

  • A dedicated AAV Workgroup of pediatric rheumatologists and nephrologists conducted a literature review.
  • Consensus conferences utilized nominal group techniques to define treatment strategies for remission induction and maintenance.
  • CARRA membership voted on the proposed CTPs, data collection, and outcome measures.

Main Results:

  • Two CTPs were developed for both remission induction and maintenance of severe pediatric AAV.
  • A glucocorticoid-weaning regimen, core data set, and outcome measures were defined.
  • CTPs for remission induction and maintenance achieved high approval rates (94% and 98%, respectively) from CARRA membership.

Conclusions:

  • Consensus methodology successfully established standardized CTPs for severe pediatric AAV.
  • The developed CTPs were broadly accepted by the CARRA membership.
  • These standardized plans will support pragmatic comparative effectiveness research in a long-term registry.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
65
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
122
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
132
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
122
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
103
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
107